These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 26076923

  • 1. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
    Wang X, Wang G, Shi J, Aa J, Comas R, Liang Y, Zhu HJ.
    Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
    [Abstract] [Full Text] [Related]

  • 2. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
    Shi J, Wang X, Eyler RF, Liang Y, Liu L, Mueller BA, Zhu HJ.
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
    [Abstract] [Full Text] [Related]

  • 3. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
    Wang X, Her L, Xiao J, Shi J, Wu AH, Bleske BE, Zhu HJ.
    Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
    [Abstract] [Full Text] [Related]

  • 4. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
    Shi J, Wang X, Nguyen J, Wu AH, Bleske BE, Zhu HJ.
    Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
    [Abstract] [Full Text] [Related]

  • 5. CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
    Zhu HJ, Langaee TY, Gong Y, Wang X, Pepine CJ, Cooper-DeHoff RM, Johnson JA, Markowitz JS.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):681-7. PubMed ID: 26915813
    [Abstract] [Full Text] [Related]

  • 6. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
    Thomsen R, Rasmussen HB, Linnet K, INDICES Consortium.
    Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
    [Abstract] [Full Text] [Related]

  • 7. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
    Shi J, Wang X, Nguyen JH, Bleske BE, Liang Y, Liu L, Zhu HJ.
    Biochem Pharmacol; 2016 Nov 01; 119():76-84. PubMed ID: 27614009
    [Abstract] [Full Text] [Related]

  • 8. A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.
    Wang X, Rida N, Shi J, Wu AH, Bleske BE, Zhu HJ.
    Drug Metab Dispos; 2017 Nov 01; 45(11):1149-1155. PubMed ID: 28838926
    [Abstract] [Full Text] [Related]

  • 9. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
    Tarkiainen EK, Tornio A, Holmberg MT, Launiainen T, Neuvonen PJ, Backman JT, Niemi M.
    Br J Clin Pharmacol; 2015 Nov 01; 80(5):1131-8. PubMed ID: 25919042
    [Abstract] [Full Text] [Related]

  • 10. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
    Her LH, Wang X, Shi J, Choi HJ, Jung SM, Smith LS, Wu AH, Bleske BE, Zhu HJ.
    Br J Clin Pharmacol; 2021 Dec 01; 87(12):4691-4700. PubMed ID: 33963573
    [Abstract] [Full Text] [Related]

  • 11. Pharmacogenetic study of CES1 gene and enalapril efficacy.
    Hussain M, Basheer S, Khalil A, Haider QUA, Saeed H, Faizan M.
    J Appl Genet; 2024 Sep 01; 65(3):463-471. PubMed ID: 38261266
    [Abstract] [Full Text] [Related]

  • 12. Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.
    Sanford JC, Wang X, Shi J, Barrie ES, Wang D, Zhu HJ, Sadee W.
    Pharmacogenet Genomics; 2016 May 01; 26(5):197-207. PubMed ID: 26871237
    [Abstract] [Full Text] [Related]

  • 13. Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis.
    Li J, Shi J, Xiao J, Tran L, Wang X, Zhu HJ.
    Drug Metab Dispos; 2022 Mar 01; 50(3):243-248. PubMed ID: 34933885
    [Abstract] [Full Text] [Related]

  • 14. The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.
    Stage C, Jürgens G, Guski LS, Thomsen R, Bjerre D, Ferrero-Miliani L, Lyauk YK, Rasmussen HB, Dalhoff K, INDICES Consortium (for members of this consortium-see Supplementum).
    Basic Clin Pharmacol Toxicol; 2017 Dec 01; 121(6):487-492. PubMed ID: 28639420
    [Abstract] [Full Text] [Related]

  • 15. Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants.
    Zhu HJ, Markowitz JS.
    Drug Metab Dispos; 2009 Feb 01; 37(2):264-7. PubMed ID: 19022936
    [Abstract] [Full Text] [Related]

  • 16. Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.
    Neuvonen M, Tarkiainen EK, Tornio A, Hirvensalo P, Tapaninen T, Paile-Hyvärinen M, Itkonen MK, Holmberg MT, Kärjä V, Männistö VT, Neuvonen PJ, Pihlajamäki J, Backman JT, Niemi M.
    Basic Clin Pharmacol Toxicol; 2018 Mar 01; 122(3):341-345. PubMed ID: 28990360
    [Abstract] [Full Text] [Related]

  • 17. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs.
    Liu D, Gao J, Zhang C, Ren X, Liu Y, Xu Y.
    Pharmazie; 2011 Nov 01; 66(11):888-93. PubMed ID: 22204136
    [Abstract] [Full Text] [Related]

  • 18. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
    Laizure SC, Parker RB, Herring VL, Hu ZY.
    Drug Metab Dispos; 2014 Feb 01; 42(2):201-6. PubMed ID: 24212379
    [Abstract] [Full Text] [Related]

  • 19. The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin.
    Qian Y, Gilliland TK, Markowitz JS.
    Chem Biol Interact; 2020 Jan 25; 316():108914. PubMed ID: 31837295
    [Abstract] [Full Text] [Related]

  • 20. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
    Zhu HJ, Wang X, Gawronski BE, Brinda BJ, Angiolillo DJ, Markowitz JS.
    J Pharmacol Exp Ther; 2013 Mar 25; 344(3):665-72. PubMed ID: 23275066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.